Liang B - Search Results

1

Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer.

Liu X, Deng J, Yuan Y, Chen W, Sun W, Wang Y, Huang H, Liang B, Ming T, Wen J, Huang B, Xing D. Liu X, et al. Among authors: liang b. Pharmacol Ther. 2022 Nov;239:108296. doi: 10.1016/j.pharmthera.2022.108296. Epub 2022 Oct 5. Pharmacol Ther. 2022. PMID: 36208791 Free article. Review.

2

Nicotinic Acid Riboside Regulates Nrf-2/P62-Related Oxidative Stress and Autophagy to Attenuate Doxorubicin-Induced Cardiomyocyte Injury.

Zou L, Liang B, Gao Y, Ye T, Li M, Zhang Y, Lu Q, Hu X, Li H, Yuan Y, Xing D. Zou L, et al. Among authors: liang b. Biomed Res Int. 2022 Feb 22;2022:6293329. doi: 10.1155/2022/6293329. eCollection 2022. Biomed Res Int. 2022. PMID: 35242876 Free PMC article. Review.

3

Targeting NAD+: is it a common strategy to delay heart aging?

Yuan Y, Liang B, Liu XL, Liu WJ, Huang BH, Yang SB, Gao YZ, Meng JS, Li MJ, Ye T, Wang CZ, Hu XK, Xing DM. Yuan Y, et al. Among authors: liang b. Cell Death Discov. 2022 Apr 26;8(1):230. doi: 10.1038/s41420-022-01031-3. Cell Death Discov. 2022. PMID: 35474295 Free PMC article. Review.

4

Recent Advances on the Role of ATGL in Cancer.

Zhang R, Meng J, Yang S, Liu W, Shi L, Zeng J, Chang J, Liang B, Liu N, Xing D. Zhang R, et al. Among authors: liang b. Front Oncol. 2022 Jul 13;12:944025. doi: 10.3389/fonc.2022.944025. eCollection 2022. Front Oncol. 2022. PMID: 35912266 Free PMC article. Review.

5

Recent advances in the screening methods of NPC1L1 inhibitors.

Zhang R, Liu W, Zeng J, Meng J, Shi L, Yang S, Chang J, Wang C, Xing K, Wen J, Liu N, Liang B, Xing D. Zhang R, et al. Among authors: liang b. Biomed Pharmacother. 2022 Nov;155:113732. doi: 10.1016/j.biopha.2022.113732. Epub 2022 Sep 24. Biomed Pharmacother. 2022. PMID: 36166964 Free article. Review.

6

First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.

Liu W, Liang B, Zeng J, Meng J, Shi L, Yang S, Chang J, Wang C, Hu X, Wang X, Han N, Lu C, Li J, Wang C, Li H, Zhang R, Xing D. Liu W, et al. Among authors: liang b. Molecules. 2022 Sep 23;27(19):6270. doi: 10.3390/molecules27196270. Molecules. 2022. PMID: 36234807 Free PMC article.

7

Advances and challenges in using nirmatrelvir and its derivatives against SARS-CoV-2 infection.

Chen W, Liang B, Wu X, Li L, Wang C, Xing D. Chen W, et al. Among authors: liang b. J Pharm Anal. 2023 Mar;13(3):255-261. doi: 10.1016/j.jpha.2022.10.005. Epub 2022 Nov 2. J Pharm Anal. 2023. PMID: 36345404 Free PMC article. Review.

8

Inhibitory Effect of Isoliquiritigenin in Niemann-Pick C1-Like 1-Mediated Cholesterol Uptake.

Zeng J, Liu W, Liang B, Shi L, Yang S, Meng J, Chang J, Hu X, Zhang R, Xing D. Zeng J, et al. Among authors: liang b. Molecules. 2022 Nov 3;27(21):7494. doi: 10.3390/molecules27217494. Molecules. 2022. PMID: 36364321 Free PMC article.

9

Review of preclinical data of PF-07304814 and its active metabolite derivatives against SARS-CoV-2 infection.

Chen W, Shao Y, Peng X, Liang B, Xu J, Xing D. Chen W, et al. Among authors: liang b. Front Pharmacol. 2022 Nov 11;13:1035969. doi: 10.3389/fphar.2022.1035969. eCollection 2022. Front Pharmacol. 2022. PMID: 36438815 Free PMC article. Review.

10

Current and future perspectives for Helicobacter pylori treatment and management: From antibiotics to probiotics.

Liang B, Yuan Y, Peng XJ, Liu XL, Hu XK, Xing DM. Liang B, et al. Front Cell Infect Microbiol. 2022 Nov 25;12:1042070. doi: 10.3389/fcimb.2022.1042070. eCollection 2022. Front Cell Infect Microbiol. 2022. PMID: 36506013 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,089 results

Search Page